PHPSX

ProFunds Pharmaceuticals UltraSector Svc
NasdaqUSDETF / FUND DELAYED
Last price
32.35
▼ 0.63 (1.91%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
32.98
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
8.24
52W range
22.47 – 41.76

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-7.86% -9.7%
1M
-17.16% -18.6%
3M
-15.20% -18.6%
6M
+19.24% +4.3%
YTD
+12.76% -1.2%
1Y
+36.73% +21.0%
3Y
+67.44% -14.4%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

7 shown · by weight
SymbolNameWeight
CRNX Crinetics Pharmaceuticals Inc 2.60%
MBX MBX Biosciences Inc 2.28%
ATAI AtaiBeckley Inc 2.03%
DFTX Definium Therapeutics Inc Ordinary Shares 2.00%
AMLX Amylyx Pharmaceuticals Inc 1.62%
ELVN Enliven Therapeutics Inc 1.59%
CORT Corcept Therapeutics Inc 1.57%

Sector exposure

Fund weightings
Healthcare
99.78%
Technology
0.22%

Fund profile

As reported
Fund familyProFunds
CategoryTrading--Leveraged Equity
Legal type—
Expense ratio2.78%
Turnover—
Total net assets—

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on PHPSX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E8.24
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
34.15
-5.28% from price
SMA 20
35.25
-8.23% from price
SMA 50
37.51
-13.77% from price
SMA 100
35.21
-8.11% from price
SMA 200
31.89
+1.45% from price
EMA 12
34.26
-5.58% from price
EMA 26
35.59
-9.12% from price
EMA 50
36.15
-10.51% from price
RSI (14)
28.8
Oversold
MACD (12,26,9)
-1.33
Hist -0.30
ATR (14)
0.66
2.04% of price
Realised vol 30D
30.6%
Annualised
Bollinger upper
38.12
20, 2σ
Bollinger lower
32.38
20, 2σ
50 / 200 cross
Golden
37.51 vs 31.89
Trend bias
Above 200
+1.45%

Options chain

Account required
Expiry
Spot 32.35
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.13
Less volatile than market
Correlation to SPY
-0.05
Largely independent
Realised vol 30D
30.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-22.5%
Peak to trough
Max drawdown 5Y
-40.5%
Peak to trough
ATR 14
0.66
2.04% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.